Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in Triple Positive Breast Cancers
Conditions: Breast Cancer; HER2-positive Breast Cancer; ER Positive Breast Cancer; PR-Positive Breast Cancer Interventions: Drug: Neratinib; Drug: Letrozole (L) or Anastrozole (A); Drug: Trastuzumab Sponsors: Ruth O'Regan; Puma Biotechnology, Inc.; University of Rochester Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Biotechnology | Cancer | Cancer & Oncology | Endocrine Therapy | HER2 | Herceptin | Research